Novavax to Sell US Government 1.5 Million More Doses of COVID-19 Vaccine

A vial of the Phase 3 Novavax COVID-19 vaccine. AP Photo/Alastair Grant

Novavax has secured a vaccine deal to provide the U.S. government with 1.5 million doses of its COVID-19 vaccine, a latecomer to a market in which the biggest buyers have stopped buying.

The Maryland-based biotech company reported on Feb. 13 that it has agreed with the U.S. government to modify an existing contract but didn’t disclose how much it will be paid for the vaccine doses.